nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.335	0.504	CbGbCtD
Tafluprost—PTGS2—Etoposide—peripheral nervous system neoplasm	0.329	0.496	CbGbCtD
Tafluprost—Ocular hyperaemia—Tretinoin—peripheral nervous system neoplasm	0.0135	0.0404	CcSEcCtD
Tafluprost—Ocular hyperaemia—Isotretinoin—peripheral nervous system neoplasm	0.0135	0.0404	CcSEcCtD
Tafluprost—Endophthalmitis—Tretinoin—peripheral nervous system neoplasm	0.0133	0.0398	CcSEcCtD
Tafluprost—Endophthalmitis—Isotretinoin—peripheral nervous system neoplasm	0.0133	0.0398	CcSEcCtD
Tafluprost—Visual acuity reduced—Tretinoin—peripheral nervous system neoplasm	0.0107	0.0318	CcSEcCtD
Tafluprost—Visual acuity reduced—Isotretinoin—peripheral nervous system neoplasm	0.0107	0.0318	CcSEcCtD
Tafluprost—Ocular hyperaemia—Alitretinoin—peripheral nervous system neoplasm	0.0103	0.0306	CcSEcCtD
Tafluprost—Endophthalmitis—Alitretinoin—peripheral nervous system neoplasm	0.0101	0.0301	CcSEcCtD
Tafluprost—Visual acuity reduced—Alitretinoin—peripheral nervous system neoplasm	0.00808	0.0241	CcSEcCtD
Tafluprost—Eye irritation—Isotretinoin—peripheral nervous system neoplasm	0.00743	0.0222	CcSEcCtD
Tafluprost—Eye irritation—Tretinoin—peripheral nervous system neoplasm	0.00743	0.0222	CcSEcCtD
Tafluprost—Lacrimation increased—Tretinoin—peripheral nervous system neoplasm	0.00689	0.0205	CcSEcCtD
Tafluprost—Lacrimation increased—Isotretinoin—peripheral nervous system neoplasm	0.00689	0.0205	CcSEcCtD
Tafluprost—Cataract—Tretinoin—peripheral nervous system neoplasm	0.00667	0.0199	CcSEcCtD
Tafluprost—Cataract—Isotretinoin—peripheral nervous system neoplasm	0.00667	0.0199	CcSEcCtD
Tafluprost—Photophobia—Tretinoin—peripheral nervous system neoplasm	0.00596	0.0178	CcSEcCtD
Tafluprost—Photophobia—Isotretinoin—peripheral nervous system neoplasm	0.00596	0.0178	CcSEcCtD
Tafluprost—Dry eye—Tretinoin—peripheral nervous system neoplasm	0.00586	0.0175	CcSEcCtD
Tafluprost—Dry eye—Isotretinoin—peripheral nervous system neoplasm	0.00586	0.0175	CcSEcCtD
Tafluprost—Eye irritation—Alitretinoin—peripheral nervous system neoplasm	0.00563	0.0168	CcSEcCtD
Tafluprost—Lacrimation increased—Alitretinoin—peripheral nervous system neoplasm	0.00522	0.0156	CcSEcCtD
Tafluprost—Cataract—Alitretinoin—peripheral nervous system neoplasm	0.00505	0.0151	CcSEcCtD
Tafluprost—Photophobia—Alitretinoin—peripheral nervous system neoplasm	0.00451	0.0135	CcSEcCtD
Tafluprost—Dry eye—Alitretinoin—peripheral nervous system neoplasm	0.00444	0.0132	CcSEcCtD
Tafluprost—Nasopharyngitis—Tretinoin—peripheral nervous system neoplasm	0.00412	0.0123	CcSEcCtD
Tafluprost—Nasopharyngitis—Isotretinoin—peripheral nervous system neoplasm	0.00412	0.0123	CcSEcCtD
Tafluprost—Asthma—Tretinoin—peripheral nervous system neoplasm	0.00398	0.0119	CcSEcCtD
Tafluprost—Asthma—Isotretinoin—peripheral nervous system neoplasm	0.00398	0.0119	CcSEcCtD
Tafluprost—Urinary tract infection—Tretinoin—peripheral nervous system neoplasm	0.00345	0.0103	CcSEcCtD
Tafluprost—Urinary tract infection—Isotretinoin—peripheral nervous system neoplasm	0.00345	0.0103	CcSEcCtD
Tafluprost—Rhinitis—Topotecan—peripheral nervous system neoplasm	0.00322	0.00961	CcSEcCtD
Tafluprost—Nasopharyngitis—Alitretinoin—peripheral nervous system neoplasm	0.00312	0.00931	CcSEcCtD
Tafluprost—Asthma—Alitretinoin—peripheral nervous system neoplasm	0.00302	0.009	CcSEcCtD
Tafluprost—Eye disorder—Isotretinoin—peripheral nervous system neoplasm	0.00298	0.00888	CcSEcCtD
Tafluprost—Eye disorder—Tretinoin—peripheral nervous system neoplasm	0.00298	0.00888	CcSEcCtD
Tafluprost—Nasopharyngitis—Cisplatin—peripheral nervous system neoplasm	0.00266	0.00793	CcSEcCtD
Tafluprost—Urinary tract infection—Alitretinoin—peripheral nervous system neoplasm	0.00261	0.0078	CcSEcCtD
Tafluprost—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00261	0.0078	CcSEcCtD
Tafluprost—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00261	0.0078	CcSEcCtD
Tafluprost—Cough—Topotecan—peripheral nervous system neoplasm	0.00244	0.00728	CcSEcCtD
Tafluprost—Cough—Tretinoin—peripheral nervous system neoplasm	0.00242	0.00722	CcSEcCtD
Tafluprost—Cough—Isotretinoin—peripheral nervous system neoplasm	0.00242	0.00722	CcSEcCtD
Tafluprost—Cough—Melphalan—peripheral nervous system neoplasm	0.00239	0.00713	CcSEcCtD
Tafluprost—Lacrimation increased—Epirubicin—peripheral nervous system neoplasm	0.00228	0.00681	CcSEcCtD
Tafluprost—Eye disorder—Alitretinoin—peripheral nervous system neoplasm	0.00226	0.00673	CcSEcCtD
Tafluprost—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00224	0.00668	CcSEcCtD
Tafluprost—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00222	0.00662	CcSEcCtD
Tafluprost—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00222	0.00662	CcSEcCtD
Tafluprost—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.00211	0.0063	CcSEcCtD
Tafluprost—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00203	0.00607	CcSEcCtD
Tafluprost—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00202	0.00602	CcSEcCtD
Tafluprost—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00202	0.00602	CcSEcCtD
Tafluprost—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00199	0.00594	CcSEcCtD
Tafluprost—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00198	0.00591	CcSEcCtD
Tafluprost—Dry eye—Epirubicin—peripheral nervous system neoplasm	0.00194	0.0058	CcSEcCtD
Tafluprost—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.00192	0.00574	CcSEcCtD
Tafluprost—Cough—Alitretinoin—peripheral nervous system neoplasm	0.00183	0.00547	CcSEcCtD
Tafluprost—Dry eye—Doxorubicin—peripheral nervous system neoplasm	0.0018	0.00536	CcSEcCtD
Tafluprost—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.00176	0.00525	CcSEcCtD
Tafluprost—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.00169	0.00505	CcSEcCtD
Tafluprost—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00169	0.00504	CcSEcCtD
Tafluprost—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00168	0.00502	CcSEcCtD
Tafluprost—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00162	0.00484	CcSEcCtD
Tafluprost—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00161	0.00482	CcSEcCtD
Tafluprost—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.0016	0.00478	CcSEcCtD
Tafluprost—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.0016	0.00478	CcSEcCtD
Tafluprost—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00158	0.00472	CcSEcCtD
Tafluprost—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.00157	0.00467	CcSEcCtD
Tafluprost—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00153	0.00456	CcSEcCtD
Tafluprost—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00143	0.00428	CcSEcCtD
Tafluprost—Cough—Etoposide—peripheral nervous system neoplasm	0.00143	0.00427	CcSEcCtD
Tafluprost—Headache—Topotecan—peripheral nervous system neoplasm	0.00143	0.00426	CcSEcCtD
Tafluprost—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00142	0.00423	CcSEcCtD
Tafluprost—Headache—Tretinoin—peripheral nervous system neoplasm	0.00142	0.00423	CcSEcCtD
Tafluprost—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00407	CcSEcCtD
Tafluprost—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00132	0.00394	CcSEcCtD
Tafluprost—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.0013	0.00389	CcSEcCtD
Tafluprost—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00377	CcSEcCtD
Tafluprost—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.00364	CcSEcCtD
Tafluprost—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00362	CcSEcCtD
Tafluprost—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00119	0.00356	CcSEcCtD
Tafluprost—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00341	CcSEcCtD
Tafluprost—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00107	0.00321	CcSEcCtD
Tafluprost—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00316	CcSEcCtD
Tafluprost—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00316	CcSEcCtD
Tafluprost—Headache—Vincristine—peripheral nervous system neoplasm	0.00104	0.00309	CcSEcCtD
Tafluprost—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000987	0.00295	CcSEcCtD
Tafluprost—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00098	0.00292	CcSEcCtD
Tafluprost—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000947	0.00283	CcSEcCtD
Tafluprost—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000914	0.00273	CcSEcCtD
Tafluprost—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000867	0.00259	CcSEcCtD
Tafluprost—Headache—Etoposide—peripheral nervous system neoplasm	0.000839	0.0025	CcSEcCtD
Tafluprost—Cough—Epirubicin—peripheral nervous system neoplasm	0.000803	0.00239	CcSEcCtD
Tafluprost—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000802	0.00239	CcSEcCtD
Tafluprost—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000743	0.00222	CcSEcCtD
Tafluprost—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000736	0.0022	CcSEcCtD
Tafluprost—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000681	0.00203	CcSEcCtD
Tafluprost—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000669	0.002	CcSEcCtD
Tafluprost—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000619	0.00185	CcSEcCtD
Tafluprost—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000531	0.00158	CcSEcCtD
Tafluprost—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000491	0.00147	CcSEcCtD
Tafluprost—Headache—Epirubicin—peripheral nervous system neoplasm	0.00047	0.0014	CcSEcCtD
Tafluprost—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.0013	CcSEcCtD
